APA (7th ed.) Citation

Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul Declerck, Marc Ferrante, Séverine Vermeire, & Erwin Dreesen. (2021). Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis. MDPI AG.

Chicago Style (17th ed.) Citation

Ruben Faelens, Zhigang Wang, Thomas Bouillon, Paul Declerck, Marc Ferrante, Séverine Vermeire, and Erwin Dreesen. Model-Informed Precision Dosing During Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement Between Patients with Ulcerative Colitis. MDPI AG, 2021.

MLA (9th ed.) Citation

Ruben Faelens, et al. Model-Informed Precision Dosing During Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement Between Patients with Ulcerative Colitis. MDPI AG, 2021.